[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fi6_7cqll7TY9qEbeIl1Om2szLjKeW1gg24T3lL5cx6Y":3,"$fkHM1FDY_SP9lW61kv1nrk6wL2T571nv8imHw6dgDaXA":108},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},14978,"2care4-aps","2care4 Aps",null,"DNK","ted-v3","https://ted.europa.eu/de/notice/-/detail/70719-2026","2026-06-11 08:38:07","2026-07-20 02:00:55",10,1326000,"2026-07-03T00:00:00.000Z",[18,37,48,58,67,81,85,93,96,104],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":32,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":36,"tender_deadline_utc":8},479767,149948,"459153-2026","https://ted.europa.eu/de/notice/-/detail/459153-2026","can-standard","2024-07-01T00:00:00.000Z","LOT-0001","Etravirin, ATC J05AG04","VAT/CVR 28964080","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2024 - 30.06.2026","DAK-Gesundheit","DE-HH","33600000","2026-07-02T22:00:00.000Z",{"award_id":38,"tender_id":39,"source_name":10,"source_award_id":40,"source_url":11,"award_notice_type":23,"award_date":41,"publication_date":42,"lot_number":25,"contract_title":43,"winner_name":44,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":45,"buyer_name":33,"region_code":46,"cpv_code":35,"tender_published_at_utc":47,"tender_deadline_utc":8},511775,40148,"70719-2026","2024-02-01T00:00:00.000Z","2026-01-30T00:00:00.000Z","Teriparatid, ATC H05AA02","2care4 ApS","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Teriparatid, ATC H05AA02 für die Zeit 01.02.2024 - 31.01.2026","DE","2026-01-29T23:00:00.000Z",{"award_id":49,"tender_id":50,"source_name":10,"source_award_id":51,"source_url":52,"award_notice_type":23,"award_date":53,"publication_date":54,"lot_number":25,"contract_title":55,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":56,"buyer_name":33,"region_code":46,"cpv_code":35,"tender_published_at_utc":57,"tender_deadline_utc":8},363913,42393,"26169-2026","https://ted.europa.eu/de/notice/-/detail/26169-2026","2024-01-01T00:00:00.000Z","2026-01-14T00:00:00.000Z","Formoterol + Beclometason (ausschließlich Darreichungsform DOS), ATC R03AK08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025","2026-01-13T23:00:00.000Z",{"award_id":59,"tender_id":60,"source_name":10,"source_award_id":61,"source_url":62,"award_notice_type":23,"award_date":53,"publication_date":63,"lot_number":25,"contract_title":64,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":65,"buyer_name":33,"region_code":46,"cpv_code":35,"tender_published_at_utc":66,"tender_deadline_utc":8},353524,42574,"20575-2026","https://ted.europa.eu/de/notice/-/detail/20575-2026","2026-01-13T00:00:00.000Z","Formoterol + Beclometason (ausschließlich Darreichungsformen IHP, INH)","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließl. Dafo. IHP, INH), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025","2026-01-12T23:00:00.000Z",{"award_id":68,"tender_id":69,"source_name":10,"source_award_id":70,"source_url":71,"award_notice_type":23,"award_date":8,"publication_date":72,"lot_number":73,"contract_title":74,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":75,"currency":28,"confidence":76,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":77,"buyer_name":78,"region_code":79,"cpv_code":35,"tender_published_at_utc":80,"tender_deadline_utc":8},54120,60801,"587252-2025","https://ted.europa.eu/de/notice/-/detail/587252-2025","2025-09-09T00:00:00.000Z","11","Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)",221000,0.92,"Deutschland – Arzneimittel – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)","AOK Baden-Württemberg","DE-BW","2025-09-08T22:00:00.000Z",{"award_id":82,"tender_id":69,"source_name":10,"source_award_id":70,"source_url":71,"award_notice_type":23,"award_date":8,"publication_date":72,"lot_number":25,"contract_title":83,"winner_name":7,"winner_identifier":84,"winner_country":9,"value_eur":75,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":77,"buyer_name":78,"region_code":79,"cpv_code":35,"tender_published_at_utc":80,"tender_deadline_utc":8},214378,"Abschluss nicht exklusiver Rabattverträge gem. § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim für den Zeitraum vom 1.10.2025 bis 31.12.2025","DE282861227",{"award_id":86,"tender_id":87,"source_name":10,"source_award_id":88,"source_url":89,"award_notice_type":23,"award_date":8,"publication_date":90,"lot_number":91,"contract_title":74,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":75,"currency":28,"confidence":76,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":77,"buyer_name":78,"region_code":79,"cpv_code":35,"tender_published_at_utc":92,"tender_deadline_utc":8},68010,71189,"427672-2025","https://ted.europa.eu/de/notice/-/detail/427672-2025","2025-07-02T00:00:00.000Z","1","2025-07-01T22:00:00.000Z",{"award_id":94,"tender_id":87,"source_name":10,"source_award_id":88,"source_url":89,"award_notice_type":23,"award_date":8,"publication_date":90,"lot_number":25,"contract_title":95,"winner_name":7,"winner_identifier":84,"winner_country":9,"value_eur":75,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":77,"buyer_name":78,"region_code":79,"cpv_code":35,"tender_published_at_utc":92,"tender_deadline_utc":8},243632,"Abschluss nicht exklusiver Rabattverträge gem. § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination Beclometason dipropionat + Formoterol hemifumarat-1-Wasser in den Darreichungsformen Inhalationspulver, mit den Wirkstärken 100/6 μg und 200/6 μg, sowie Dosieraerosol/Inhalat mit der Wirkstärke 200/6 μg für den Zeitraum vom 1.7.2025 bis 31.12.2025",{"award_id":97,"tender_id":98,"source_name":10,"source_award_id":99,"source_url":100,"award_notice_type":23,"award_date":8,"publication_date":101,"lot_number":102,"contract_title":74,"winner_name":44,"winner_identifier":8,"winner_country":8,"value_eur":75,"currency":28,"confidence":76,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":77,"buyer_name":78,"region_code":79,"cpv_code":35,"tender_published_at_utc":103,"tender_deadline_utc":8},115533,107356,"614300-2024","https://ted.europa.eu/de/notice/-/detail/614300-2024","2024-10-11T00:00:00.000Z","2","2024-10-10T22:00:00.000Z",{"award_id":105,"tender_id":98,"source_name":10,"source_award_id":99,"source_url":100,"award_notice_type":23,"award_date":8,"publication_date":101,"lot_number":25,"contract_title":106,"winner_name":44,"winner_identifier":107,"winner_country":9,"value_eur":75,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":77,"buyer_name":78,"region_code":79,"cpv_code":35,"tender_published_at_utc":103,"tender_deadline_utc":8},210022,"Abschluss nicht exklusiver Rabattverträge gem. § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tocilizumab für den Zeitraum vom 1.10.2024 bis 30.6.2025","DE282 861 227",{"company_slug":6,"years":109,"award_count":14,"top_buyers":110,"yearly_trend":120},5,[111,115],{"buyer_name":78,"buyer_key":112,"award_count":113,"total_value_eur":15,"share_count":114},"aok-baden-wuerttemberg",6,0.6,{"buyer_name":33,"buyer_key":116,"award_count":117,"total_value_eur":118,"share_count":119},"dak-gesundheit",4,0,0.4,[121,124,126],{"year":122,"award_count":123},2024,2,{"year":125,"award_count":117},2025,{"year":127,"award_count":117},2026]